Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11532)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2017 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E. Association between endotoxemia and histological features of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(4): 712-722 [PMID: 28216979 DOI: 10.3748/wjg.v23.i4.712] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i4/712.htm |
| Number | Citing Articles |
| 1 |
Qian He, Jun Zeng, Kecheng Yao, Wei Wang, Qiong Wu, Renmin Tang, Xuan Xia, Xiulan Zou. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling. Biochemical and Biophysical Research Communications 2020; 532(3): 362 doi: 10.1016/j.bbrc.2020.08.036
|
| 2 |
Devi Basumatary, Santanu Das, M. Bidyarani Devi, G. Shalini Devi, Pranamika Sarma, Ashis K. Mukherjee, Mojibur R. Khan, Jagat C. Borah. Garcinol enriched fraction of Garcinia morella (Gaertn.) Desr. fruit rind improves gut health and reduces the risk of nonalcoholic fatty liver disease by regulating PCK1/ACC/SREBP1/FASn pathway in a mouse model. Food Research International 2024; 197: 115285 doi: 10.1016/j.foodres.2024.115285
|
| 3 |
Yuzhen Wang, Jimin Zheng, Hongtao Hou, Jian Zhang, Shuangfei Qi, Yueqin Li, Nasser Hadal Alotaibi, Khalid Saad Alharbi, Syed Nasir Abbas Bukhari. Effects of berberine on intestinal flora of Non-alcoholic fatty liver induced by High-fat diet through 16S rRNA gene segmentation. Journal of King Saud University - Science 2020; 32(5): 2603 doi: 10.1016/j.jksus.2020.04.020
|
| 4 |
Kanav Kaushal, Vipin Gupta, Pooja Goswami, Samagra Agarwal, Sanchit Sharma, Prasenjit Das, Rajni Yadav, Abhinav Anand, Ujjwal Sonika, Deepak Gunjan, Anoop Saraya. Acute Variceal Bleed in Cirrhosis is Associated With Reversible Changes in Tight Junction Protein Expression in the Intestine: A Proof-of-Concept Study. Journal of Clinical and Experimental Hepatology 2022; 12(1): 89 doi: 10.1016/j.jceh.2021.03.009
|
| 5 |
Weifang Huang, Desong Kong. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD. Biomedicine & Pharmacotherapy 2021; 135: 111235 doi: 10.1016/j.biopha.2021.111235
|
| 6 |
Waleska Dornas, Vincent Lagente. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. Pharmacological Research 2019; 141: 418 doi: 10.1016/j.phrs.2019.01.026
|
| 7 |
Seonghwan Hwang, Hwayoung Yun, Sungwon Moon, Ye Eun Cho, Bin Gao. Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.751802
|
| 8 |
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Michiharu Komatsu, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. World Journal of Gastroenterology 2018; 24(13): 1440-1450 doi: 10.3748/wjg.v24.i13.1440
|
| 9 |
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, Tom Houben. Prevention and Treatment of Atherosclerosis. Handbook of Experimental Pharmacology 2020; 270: 233 doi: 10.1007/164_2020_352
|
| 10 |
Wei Perng, Jacob E Friedman, Rachel C Janssen, Deborah H Glueck, Dana Dabelea. Endotoxin Biomarkers Are Associated With Adiposity and Cardiometabolic Risk Across 6 Years of Follow-up in Youth. The Journal of Clinical Endocrinology & Metabolism 2022; 107(7): e3018 doi: 10.1210/clinem/dgac149
|
| 11 |
Naoyuki Fujimori, Takeji Umemura, Takefumi Kimura, Naoki Tanaka, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Michiharu Komatsu, Yoko Usami, Kenji Sano, Koji Igarashi, Akihiro Matsumoto, Eiji Tanaka. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(11): 1239-1249 doi: 10.3748/wjg.v24.i11.1239
|
| 12 |
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. Journal of Medicinal Food 2019; 22(7): 729 doi: 10.1089/jmf.2018.0020
|
| 13 |
Naoki Tanaka, Toshifumi Aoyama, Shioko Kimura, Frank J. Gonzalez. Targeting nuclear receptors for the treatment of fatty liver disease. Pharmacology & Therapeutics 2017; 179: 142 doi: 10.1016/j.pharmthera.2017.05.011
|
| 14 |
L. Valenti, S. Romeo. Editorial: new insights into the relationship between the intestine and non‐alcoholic fatty liver—is “fatty gut” involved in disease progression?. Alimentary Pharmacology & Therapeutics 2017; 46(3): 377 doi: 10.1111/apt.14154
|
| 15 |
Bin Liu, Liping Xiang, Jing Ji, Wei Liu, Ying Chen, Mingfeng Xia, Yuejun Liu, Wenyue Liu, Peiwu Zhu, Yi Jin, Yu Han, Jieli Lu, Xiaoying Li, Minghua Zheng, Yan Lu. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2. Journal of Clinical Investigation 2021; 131(20) doi: 10.1172/JCI144801
|
| 16 |
Josefin Soppert, Elisa Fabiana Brandt, Nicole Maria Heussen, Emona Barzakova, Lars Mathias Blank, Lars Kuepfer, Mathias Walter Hornef, Jonel Trebicka, Joachim Jankowski, Marie-Luise Berres, Heidi Noels. Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2023; 21(11): 2746 doi: 10.1016/j.cgh.2022.11.030
|
| 17 |
Anna Gudan, Dominika Jamioł-Milc, Victoria Hawryłkowicz, Karolina Skonieczna-Żydecka, Ewa Stachowska. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-Regression. Nutrients 2022; 14(24): 5261 doi: 10.3390/nu14245261
|
| 18 |
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASH. Nature Reviews Gastroenterology & Hepatology 2018; 15(6): 349 doi: 10.1038/s41575-018-0009-6
|
| 19 |
Josh Bilson, Jaswinder K. Sethi, Christopher D. Byrne. Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function. Proceedings of the Nutrition Society 2022; 81(2): 146 doi: 10.1017/S0029665121003815
|
| 20 |
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes. A Microphysiological System for Studying Nonalcoholic Steatohepatitis. Hepatology Communications 2020; 4(1): 77 doi: 10.1002/hep4.1450
|
| 21 |
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
|
| 22 |
Ye Eun Cho, Yong Seong Kwon, Seonghwan Hwang. Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease. Liver Research 2023; 7(1): 16 doi: 10.1016/j.livres.2022.06.001
|
| 23 |
Jessica Latorre, Ramon Díaz-Trelles, Ferran Comas, Aleix Gavaldà-Navarro, Edward Milbank, Nathalia Dragano, Samantha Morón-Ros, Rajesh Mukthavaram, Francisco Ortega, Anna Castells-Nobau, Núria Oliveras-Cañellas, Wifredo Ricart, Priya P. Karmali, Kiyoshi Tachikawa, Pad Chivukula, Francesc Villarroya, Miguel López, Marta Giralt, José Manuel Fernández-Real, José María Moreno-Navarrete. Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation. Molecular Therapy - Nucleic Acids 2022; 29: 599 doi: 10.1016/j.omtn.2022.08.003
|
| 24 |
Teresa Auguet, Laia Bertran, Andrea Barrientos-Riosalido, Blanca Fabregat, Beatriz Villar, Carmen Aguilar, Fàtima Sabench. Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?. International Journal of Environmental Research and Public Health 2022; 19(20): 13495 doi: 10.3390/ijerph192013495
|
| 25 |
Guy C. Brown, Marta Camacho, Caroline H. Williams‐Gray. The Endotoxin Hypothesis of Parkinson's Disease. Movement Disorders 2023; 38(7): 1143 doi: 10.1002/mds.29432
|
| 26 |
Ina Bergheim, José María Moreno‐Navarrete. The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction‐associated steatotic liver disease. European Journal of Clinical Investigation 2024; 54(7) doi: 10.1111/eci.14224
|
| 27 |
Ayla Coussa, Hayder A. Hasan, Thomas M. Barber. Early Predictors of Gestational Diabetes Mellitus in IVF-Conceived Pregnancies. Endocrine Practice 2021; 27(6): 579 doi: 10.1016/j.eprac.2020.10.020
|
| 28 |
Kanav Kaushal, Samagra Agarwal, Sanchit Sharma, Pooja Goswami, Namrata Singh, Vikas Sachdev, Shekhar Poudel, Prasenjit Das, Rajni Yadav, Dinesh Kumar, Gaurav Pandey, Deepak Gunjan, Anoop Saraya. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study. Journal of Clinical and Experimental Hepatology 2022; 12(4): 1102 doi: 10.1016/j.jceh.2022.01.006
|
| 29 |
Anjana Sajeev, Mangala Hegde, Sosmitha Girisa, Thulasidharan Nair Devanarayanan, Mohammed S. Alqahtani, Mohamed Abbas, Samir Kumar Sil, Gautam Sethi, Jen-Tsung Chen, Ajaikumar B. Kunnumakkara. Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases. Biomolecules 2022; 12(9): 1185 doi: 10.3390/biom12091185
|
| 30 |
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Kenji Sano, Akira Horiuchi, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Miglitol attenuates non‐alcoholic steatohepatitis in diabetic patients. Hepatology Research 2018; 48(13): 1092 doi: 10.1111/hepr.13223
|
| 31 |
Leke Wiering, Frank Tacke. Treating inflammation to combat non-alcoholic fatty liver disease. Journal of Endocrinology 2023; 256(1) doi: 10.1530/JOE-22-0194
|
| 32 |
Aleksandra Białczyk, Alicja Rajewska, Roman Junik, Szymon Suwała. The Role of Probiotics in Managing Metabolic-Associated Fatty Liver Disease: An Updated Review. Current Research in Nutrition and Food Science Journal 2024; 12(2): 490 doi: 10.12944/CRNFSJ.12.2.2
|
| 33 |
Qian Song, Xiang Zhang. The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Biomedicines 2022; 10(3): 524 doi: 10.3390/biomedicines10030524
|
| 34 |
Penghui Nie, Liehai Hu, Xiaoyan Feng, Hengyi Xu. Gut Microbiota Disorders and Metabolic Syndrome: Tales of a Crosstalk Process. Nutrition Reviews 2024; doi: 10.1093/nutrit/nuae157
|
| 35 |
Shusong Wu, Ruizhi Hu, Hironobu Nakano, Keyu Chen, Ming Liu, Xi He, Hongfu Zhang, Jianhua He, De-Xing Hou. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. Molecules 2018; 23(12): 3213 doi: 10.3390/molecules23123213
|
| 36 |
A. A. Iakupova, S. R. Abdulkhakov, R. K. Zalyalov, A. G. Safin, R. A. Abdulkhakov. Intestinal Permeability Assays: a Review. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(1): 20 doi: 10.22416/1382-4376-2021-31-1-20-30
|
| 37 |
Takefumi Kimura, Simran Singh, Naoki Tanaka, Takeji Umemura. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.773432
|
| 38 |
Martin J. Page, Douglas B. Kell, Etheresia Pretorius. The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation. Chronic Stress 2022; 6 doi: 10.1177/24705470221076390
|
| 39 |
Guido Carpino, Maria Del Ben, Daniele Pastori, Roberto Carnevale, Francesco Baratta, Diletta Overi, Heather Francis, Vincenzo Cardinale, Paolo Onori, Samira Safarikia, Vittoria Cammisotto, Domenico Alvaro, Gianluca Svegliati‐Baroni, Francesco Angelico, Eugenio Gaudio, Francesco Violi. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. Hepatology 2020; 72(2): 470 doi: 10.1002/hep.31056
|